Axial Therapeutics, Inc.

📍 Waltham, United States🗓 Founded 2016👥 6 employees💰 Last funded Mar 2019
Biotechnology Research🌐 axialtx.com
Website LinkedIn
Axial Therapeutics™ is a clinical-stage biopharmaceutical company focused on the discovery and development of gut-restricted, small molecule therapeutics for central nervous system (CNS) disorders. The company is leveraging its expertise in the gut-brain axis and its unique drug development platform to advance novel therapies that have the potential to transform the treatment paradigm in neurodegenerative diseases.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Switzerland
1
United States
1
Frequently asked questions
Who invested in Axial Therapeutics, Inc.?
Axial Therapeutics, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Axial Therapeutics, Inc. last raise funding?
The most recent investment in Axial Therapeutics, Inc. recorded on gritt.io was in March 2019.
When was Axial Therapeutics, Inc. founded?
Axial Therapeutics, Inc. was founded in 2016.
What industry is Axial Therapeutics, Inc. in?
Axial Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Axial Therapeutics, Inc. based?
Axial Therapeutics, Inc. is headquartered in Waltham, United States.